Sale

Peripheral Artery Disease Market

Global Peripheral Artery Disease Market Share, Growth, Size, Outlook, Report: By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Others; By Treatment; By Distribution Channel; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Peripheral Artery Disease Market Outlook

The global peripheral artery disease market size attained a value of USD 4.42 billion in 2023, driven by increasing geriatric population, unhealthy lifestyles led by the adults, increasing prevalence of obesity, diabetes, and high blood pressure, among others. The market is anticipated to grow at a CAGR of 6.3% during the forecast period of 2024-2032 to attain a value of USD 7.66 billion by 2032.

 

Global Peripheral Artery Disease Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

According to the peripheral artery disease market report, peripheral artery disease or PAD is widely prevalent and is considered as a disease which is a large contributor towards the growing burden of cardiovascular diseases. The peripheral artery disease market overview suggests that the technological advancements in endovascular and surgical treatments of peripheral artery disease are fuelling the market growth. In the coming years, the peripheral arterial disease market is also projected to witness growth, driven by the increasing prevalence of atherosclerosis. Increasing awareness regarding peripheral artery disease is resulting in more patients seeking diagnostics and treatment at an earlier stage, promoting better outcomes.

 

The Asia Pacific to Grow at a Steady Pace During the Forecast Period with the Growing Population

According to the peripheral artery disease market research, Asia Pacific is expected to have a significant market share in the forecast period. There are a variety of factors driving the growth of peripheral artery disease market in the Asia Pacific region. One of the key factors is the large population with unmet medical conditions such as obesity, diabetes, and high blood pressure, which might propel the risk of peripheral artery disease. In addition, the healthcare infrastructure in the region has been growing significantly along with the GDP, which is expected to enlarge the peripheral artery disease market size in the forecast period. Moreover, there have been some notable developments amongst the leading players in the market, leading to increased competition globally and expanded growth of the global peripheral artery disease market size. Meanwhile, in North America, prevalent lifestyle issues such as obesity and lack of intake of proper diet in strong economies such as the United States are expanding the peripheral artery disease US market size.

 

Peripheral Artery Disease: Market Segmentation

Peripheral artery disease is a medical term that refers to the narrowing of arteries in human body that reduces the flow of blood in the lower body including legs. As a result, the oxygen and blood levels in the lower body reach below the required level, consequently leading to pain in walking. Peripheral artery disease can also be a sign of blocking or clogging of the arteries. This can usually be treated by lifestyle modification, regular exercise, and quitting tobacco in any form.

 

Global Peripheral Artery Disease Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The peripheral artery disease market segmentation based on type is:

  • Peripheral Angioplasty Balloons
    • Breakup by Type
      • Old/Normal Balloons
      • Cutting and Scoring Balloons
      • Drug-Coated Balloons
      • Peripheral Stents
    • Breakup by Type
      • Self-Expandable
      • Balloon-Expandable
      • Covered Stents
      • Drug-Eluting Stents
      • Peripheral Catheters
    • Breakup by Type
      • Angiography Catheters
      • Guiding Catheters
      • Inferior Vena Cava (IVC) Filters
    • Breakup by Type
      • Permanent Filters
      • Retrievable Filters
      • Plaque Modification Devices
    • Breakup by Type
      • Thrombectomy Devices
      • Atherectomy Devices
      • Haemodynamic Flow Alteration Devices
    • Breakup by Type
      • Embolic Protection Devices
      • Chronic Total Occlusion Devices
      • Peripheral Accessories
    • Breakup by Type
      • Peripheral Vascular Closure Devices
      • Introducer Sheaths
      • Guidewires
      • Balloon Inflation Devices
      • Others

 

The EMR report looks into the regional markets of peripheral artery disease like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Peripheral Artery Disease Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Demand for Non-Invasive Procedures, coupled with Unhealthy Lifestyles to Propel the Demand for Peripheral Artery Disease Treatment

As per the peripheral artery disease market analysis, evolving health infrastructure has increased the usage of interventional devices like drug-eluting agents, atherectomy devices, and others, which is aiding the diagnostics infrastructure, leading to a heightened growth of peripheral arterial disease diagnostics market. Atherectomy is used to remove the plaque in arteries with the help of catheter and its demand in treating peripheral artery diseases (PADs) has increased majorly. Further, the demand for non-invasive or minimally-invasive endovascular procedures has increased recently because they offer shorter recovery time and minimal chances of post-surgery complications. This factor is further likely to boost the peripheral artery disease market share in the global healthcare industry. Moreover, the unhealthy lifestyle led by people worldwide, coupled with increased consumption of alcohols, tobacco, and smoking is anticipated to spike the number of cardiac arrests, blood clotting, and other heart conditions in the coming years, thereby boosting the demand for peripheral artery disease drugs, leading to an enlargement of the peripheral artery disease drugs market size.

 

The surge in geriatric population at a global level is likely to boost the susceptibility to peripheral artery diseases in the future. In this regard, initiatives taken to aid the health of geriatrics and favourable reimbursement policies of the government are the critical peripheral artery disease market trends. There is a clear correlation between ageing and occurrence of medical conditions such as diabetes, blood pressure, and heart related diseases, among others. This factor is likely to add to the peripheral artery disease market value in the forecast period. In addition, there have been mergers and acquisitions among the leading market players, which are expected to be the crucial driving factors propelling the growth of peripheral artery disease global market.

 

Key Industry Players in the Global Peripheral Artery Disease Market

The report presents a detailed analysis of the following key players in the global peripheral artery disease market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

 

  • AngioDynamics Inc.
  • B. Braun Melsungen AG
  • Biotronik Inc.
  • Boston Scientific Corp.
  • Cook Group Incorporated
  • Terumo Corporation
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • W. L. Gore & Associates, Inc.
  • LeMaitre Vascular, Inc.
  • Others

 

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Treatment
  • Distribution Channel
  • End User
  • Region
Breakup by Type
  • Peripheral Angioplasty Balloons
  • Peripheral Stents
  • Peripheral Catheters
  • Inferior Vena Cava (IVC) Filters
  • Plaque Modification Devices
  • Haemodynamic Flow Alteration Devices
  • Peripheral Accessories
Breakup by Treatment
  • Oral
  • Parenteral
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • AngioDynamics Inc.
  • B. Braun Melsungen AG
  • Biotronik Inc.
  • Boston Scientific Corp.
  • Cook Group Incorporated
  • Terumo Corporation
  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • W. L. Gore & Associates, Inc.
  • LeMaitre Vascular, Inc.
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Peripheral Artery Disease Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Peripheral Artery Disease Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Peripheral Artery Disease Epidemiology (2016-2031)
    5.3    Europe Peripheral Artery Disease Epidemiology (2016-2031)
    5.4    Asia-Pacific Peripheral Artery Disease Epidemiology (2016-2031)
    5.5    Latin America Peripheral Artery Disease Epidemiology (2016-2031)
    5.6    Middle East & Africa Peripheral Artery Disease Epidemiology (2016-2031)
6    Global Peripheral Artery Disease Market Overview 
    6.1    Global Peripheral Artery Disease Market Historical Value (2017-2023) 
    6.2    Global Peripheral Artery Disease Market Forecast Value (2024-2032)
7    Global Peripheral Artery Disease Market Landscape
    7.1    Peripheral Artery Disease: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Peripheral Artery Disease: Product Landscape
        7.2.1    Analysis by Type
        7.2.2    Analysis by Treatment
        7.2.3    Analysis by Distribution Channel
        7.2.4    Analysis by End User
8    Peripheral Artery Disease Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Peripheral Artery Disease Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Peripheral Artery Disease Market Segmentation
    11.1    Global Peripheral Artery Disease Market by Type
        11.1.1    Market Overview
        11.1.2    Peripheral Angioplasty Balloons
            11.1.2.1    Old/Normal Balloons
            11.1.2.2    Cutting and Scoring Balloons
            11.1.2.3    Drug-Coated Balloons
        11.1.3    Peripheral Stents
            11.1.3.1    Self-Expandable 
            11.1.3.2    Balloon-Expandable
            11.1.3.3    Covered Stents
            11.1.3.4    Drug-Eluting Stents
        11.1.4    Peripheral Catheters
            11.1.4.1    Angiography Catheters
            11.1.4.2    Guiding Catheters
        11.1.5    Inferior Vena Cava (IVC) Filters
            11.1.5.1    Permanent Filters
            11.1.5.2    Retrievable Filters
        11.1.6    Plaque Modification Devices
            11.1.6.1    Thrombectomy Devices
            11.1.6.2    Atherectomy Devices
        11.1.7    Haemodynamic Flow Alteration Devices
            11.1.7.1    Embolic Protection Devices
            11.1.7.2    Chronic Total Occlusion Devices
        11.1.8    Peripheral Accessories
            11.1.8.1    Peripheral Vascular Closure Devices
            11.1.8.2    Introducer Sheaths
            11.1.8.3    Guidewires
            11.1.8.4    Balloon Inflation Devices
    11.2    Global Peripheral Artery Disease Market by Treatment
        11.2.1    Market Overview
        11.2.2    Oral
        11.2.3    Parenteral
        11.2.4    Others
    11.3    Global Peripheral Artery Disease Market by Distribution Channel
        11.3.1    Market Overview
        11.3.2    Hospital Pharmacy
        11.3.3    Retail Pharmacy
        11.3.4    Others
    11.4    Global Peripheral Artery Disease Market by End User
        11.4.1    Market Overview
        11.4.2    Hospitals 
        11.4.3    Specialty Clinics
        11.4.4    Others
    11.5    Global Peripheral Artery Disease Market by Region
        11.5.1    Market Overview
        11.5.2    North America
        11.5.3    Europe 
        11.5.4    Asia Pacific
        11.5.5    Latin America
        11.5.6    Middle East and Africa
12    North America Peripheral Artery Disease Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Peripheral Artery Disease Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Peripheral Artery Disease Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Peripheral Artery Disease Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Peripheral Artery Disease Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    AngioDynamics Inc.
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    B. Braun Melsungen AG
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Biotronik Inc.
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Boston Scientific Corp.
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    Cook Group Incorporated
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Terumo Corporation
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Koninklijke Philips N.V.
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Becton, Dickinson and Company
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    W. L. Gore & Associates, Inc.
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    LeMaitre Vascular, Inc.
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
24    Peripheral Artery Disease - Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global market peripheral artery disease attained a value of USD 4.42 billion.

The market is anticipated to grow at a CAGR of 6.3% during the forecast period of 2024-2032 to reach a value of USD 7.66 billion by 2032.

The major drivers of the market include the increasing geriatric population, unhealthy lifestyles led by the adults, increasing prevalence of obesity, diabetes, and high blood pressure, among others.

The rising healthcare expenditure and the growing demand for minimally-invasive procedures to treat peripheral artery disease are expected to be the key trends guiding the growth of the industry.

What are the major regional markets of peripheral artery disease, according to the EMR report?

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, haemodynamic flow alteration devices, and peripheral accessories, among others are the major types based on which the market has been segmented.

The major players in the peripheral artery disease market are AngioDynamics Inc., B. Braun Melsungen AG, Biotronik Inc., Boston Scientific Corp., Cook Group Incorporated, Terumo Corporation, Koninklijke Philips N.V., Becton, Dickinson and Company., W. L. Gore & Associates, Inc., and LeMaitre Vascular, Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 7999     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 9999     $5999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER